|
MTBP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.85550000048651E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.1886000000031E-05 |
| Normal-vs-Stage2 |
4.564700E-04 |
| Normal-vs-Stage3 |
2.396500E-04 |
| Normal-vs-Stage4 |
2.818600E-04 |
| Stage1-vs-Stage2 |
9.468000E-02 |
| Stage1-vs-Stage3 |
3.057400E-01 |
| Stage1-vs-Stage4 |
5.586100E-02 |
| Stage2-vs-Stage3 |
3.548800E-01 |
| Stage2-vs-Stage4 |
7.712400E-01 |
| Stage3-vs-Stage4 |
2.397200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.36300000028878E-07 |
| Normal-vs-AfricanAmerican |
2.514100E-02 |
| Normal-vs-Asian |
1.648220E-01 |
| Caucasian-vs-AfricanAmerican |
6.922200E-02 |
| Caucasian-vs-Asian |
3.911600E-01 |
| AfricanAmerican-vs-Asian |
2.807000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.09540000001485E-06 |
| Normal-vs-Female |
1.87697999999292E-05 |
| Male-vs-Female |
9.040800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.723300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.06319999995763E-06 |
| Normal-vs-Age(61-80Yrs) |
2.04929999999548E-05 |
| Normal-vs-Age(81-100Yrs) |
1.007030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.963600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.980600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.325600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.750400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.015400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.584000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.020900E-03 |
| Normal-vs-Grade 2 |
1.26850000004008E-06 |
| Normal-vs-Grade 3 |
5.442700E-04 |
| Normal-vs-Grade 4 |
1.456470E-03 |
| Grade 1-vs-Grade 2 |
7.951000E-01 |
| Grade 1-vs-Grade 3 |
4.379400E-01 |
| Grade 1-vs-Grade 4 |
4.419400E-01 |
| Grade 2-vs-Grade 3 |
1.122790E-01 |
| Grade 2-vs-Grade 4 |
2.873600E-01 |
| Grade 3-vs-Grade 4 |
9.736100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.14270000004269E-06 |
| Normal-vs-ccB subtype |
1.970970E-04 |
| ccA subtype-vs-ccB subtype |
9.722800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68130000000044E-06 |
| Normal-vs-N1 |
6.217800E-03 |
| N0-vs-N1 |
2.103400E-01 |
|
|
